throbber
4140–4156 Nucleic Acids Research, 2005, Vol. 33, No. 13
`doi:10.1093/nar/gki732
`
`Functional polarity is introduced by Dicer
`processing of short substrate RNAs
`Scott D. Rose, Dong-Ho Kim1, Mohammed Amarzguioui1, Jeremy D. Heidel2,
`Michael A. Collingwood, Mark E. Davis2, John J. Rossi1,3 and
`Mark A. Behlke*
`
`Integrated DNA Technologies, Inc. 1710 Commercial Park, Coralville, IA 52241, USA, 1Division of Molecular Biology,
`Beckman Research Institute of the City of Hope, 1450 East Duarte Road, Duarte, CA 91010-3011, USA,
`2Chemical Engineering, California Institute of Technology, 1200 E. California Boulevard, Pasadena, CA 91125, USA
`and 3Graduate School of Biological Sciences, City of Hope and Beckman Research Institute of the City of Hope,
`1450 East Duarte Road, Duarte, CA 91010-3011, USA
`
`Received May 13, 2005; Revised and Accepted July 6, 2005
`
`ABSTRACT
`
`Synthetic RNA duplexes that are substrates for Dicer
`are potent triggers of RNA interference (RNAi). Blunt
`27mer duplexes can be up to 100-fold more potent
`than traditional 21mer duplexes (1). Not all 27mer
`duplexes show increased potency. Evaluation of
`the products of in vitro dicing reactions using elec-
`trospray ionization mass spectrometry reveals that
`a variety of products can be produced by Dicer cleav-
`age. Use of asymmetric duplexes having a single
`2-base 30-overhang restricts the heterogeneity that
`results from dicing. Inclusion of DNA residues at
`the ends of blunt duplexes also limits heterogeneity.
`Combination of asymmetric 2-base 30-overhang with
`30-DNA residues on the blunt end result in a duplex
`form which directs dicing to predictably yield a single
`primary cleavage product. It is therefore possible to
`design a 27mer duplex which is processed by Dicer to
`yield a specific, desired 21mer species. Using this
`strategy, two different 27mers can be designed that
`result in the same 21mer after dicing, one where the
`30-overhang resides on the antisense (AS) strand and
`dicing proceeds to the ‘right’ (‘R’) and one where the
`30-overhang resides on the sense (S) strand and dicing
`proceeds to the ‘left’ (‘L’). Interestingly, the ‘R’ version
`of the asymmetric 27mer is generally more potent in
`reducing target gene levels than the ‘L’ version 27mer.
`Strand targeting experiments show asymmetric
`strand utilization between the two different 27mer
`forms, with the ‘R’ form favoring S strand and the
`‘L’ form favoring AS strand silencing. Thus, Dicer
`
`processing confers functional polarity within the
`RNAi pathway.
`
`INTRODUCTION
`
`RNA interference (RNAi) is a conserved pathway present
`in most eukaryotes where double-stranded RNA (dsRNA)
`triggers a series of biochemical events that culminates in
`sequence-specific suppression of gene expression (2–4).
`Long dsRNAs have been employed for many years as a means
`to modulate gene expression in plants (5), yeast (6) and
`Caenorhabditis elegans (7). Similar attempts in mammalian
`cells failed due to interferon activation. In Drosophila, dsRNA
`of >150 bp length efficiently induces an RNAi response. This
`response becomes weaker as RNA length decreases and
`25–38 bp duplexes are inactive; very short duplexes of 19–
`23 bp length regain activity (8). The biochemistry is slightly
`different in mammalian cells and 25–30 bp duplexes will
`strongly induce an RNAi response, but potency does decrease
`with length and 45 bp duplexes are mostly inactive (1). In vivo,
`long dsRNAs are cleaved by the RNase III class endoribo-
`nuclease Dicer into 21–23 base duplexes having 2-base
`30-overhangs (9,10). These species, called ‘small interfering
`RNAs’ (siRNAs), enter the RNA induced silencing complex
`(RISC) and serve as a sequence-specific guide to target
`degradation of complementary mRNA species (8).
`The discovery of siRNAs permitted RNAi to be used as an
`experimental tool in higher eukaryotes. Typically, siRNAs are
`chemically synthesized as 21mers with a central 19 bp duplex
`region and symmetric 2-base 30-overhangs on the termini.
`These duplexes are transfected into cells lines, directly mim-
`icking the products made by Dicer in vivo. Most siRNA
`sequences can be administered to cultured cells or to animals
`without eliciting an interferon response (11–13). There are
`
`*To whom correspondence should be addressed. Tel: +1 319 626 8432; Fax: +1 319 626 8444; Email: mbehlke@idtdna.com
`
`Ó The Author 2005. Published by Oxford University Press. All rights reserved.
`
`The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access
`version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press
`are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but
`only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oupjournals.org
`
`Alnylam Exh. 1086
`
`

`

`some reports that particular motifs can induce such a response
`when delivered via lipids (13–15), although a cyclodextrin-
`containing polycation system has been shown to deliver
`siRNA containing one such putative immunostimulatory
`motif that achieves target gene down-regulation in mice
`without triggering an interferon response (16), even in a
`disseminated tumor model.
`RNAi has rapidly become the favored method to knock
`down single genes for detailed study or hundreds to thousands
`of genes in high-throughput functional genomics surveys. The
`potential of 21mer siRNAs for use as therapeutic agents to
`reduce activity of specific gene products is also receiving
`considerable attention and successful knockdown of gene
`expression in mice has already been demonstrated by several
`groups (17–20).
`We recently described that chemically synthesized RNA
`duplexes of 25–30 base length can have as much as a
`100-fold increase in potency compared with 21mers at the
`same location. At the site most extensively examined in this
`study, EGFPS1, only minor differences in potency were seen
`between duplexes with blunt, 30-overhang or 50-overhang ends,
`and a blunt 27mer duplex was most potent (1). Increased
`potency has similarly been described for 29mer stem short
`hairpin RNAs (shRNAs) when compared with 19mer stem
`hairpins (21). While the primary function of Dicer is generally
`thought to be cleavage of long substrate dsRNAs into short
`siRNA products, Dicer also introduces the cleaved siRNA
`duplexes into nascent RISC in Drosophila (22–24). Dicer is
`involved in RISC assembly and is itself part of the pre-RISC
`complex (25). The observed increased potency obtained using
`longer RNAs in triggering RNAi is theorized to result from
`providing Dicer with a substrate (27mer) instead of a product
`(21mer) and that this improves the rate or efficiency of entry
`of the siRNA duplex into RISC.
`Unfortunately, not all 27mers show this kind of increased
`potency. It is well known that shifting a 21mer siRNA by a
`few bases along the mRNA sequence can change its potency
`by 10-fold or more (26–28). Different products that result from
`dicing can have different functional potency, and control of
`the dicing reaction may be necessary to best utilize Dicer–
`substrate RNAs in RNAi. The EGFPS1 blunt 27mer studied in
`Kim et al. (1) is diced into two distinct 21mers. Vermeulen
`and colleagues reported studies where synthetic 61mer duplex
`RNAs were digested using recombinant human Dicer in vitro
`and examined for cut sites using a 32P-end-labeled gel assay
`system. Heterogeneous cleavage patterns were observed and
`the presence of blunt versus 30-overhang ends altered precise
`cleavage sites (29). Dicing patterns for short 25–30mer RNA
`substrates have not been published and processing rules that
`enable accurate prediction of these patterns do not exist. We
`therefore studied dicing patterns at a variety of sites using
`different duplex designs to see if cleavage products could
`be predicted. We find that a wide variety of dicing patterns
`can result from blunt 27mer duplexes. An asymmetric duplex
`having a single 2-base 30-overhang generally has a more pre-
`dictable and limited dicing pattern where a major cleavage site
`is located 21–22 bases from the overhang. Including DNA
`residues at the 30 end of the blunt side of an asymmetric duplex
`further limits heterogeneity in dicing patterns and makes it
`possible to design 27mer duplexes that result in predictable
`products after dicing.
`
`Nucleic Acids Research, 2005, Vol. 33, No. 13
`
`4141
`
`the 30-overhang influences
`We find that position of
`potency and asymmetric duplexes having a 30-overhang on
`the antisense strand are generally more potent than those
`with the 30-overhang on the sense strand. This can be attri-
`buted to asymmetrical strand loading into RISC, as the
`opposite efficacy patterns are observed when targeting the
`antisense transcript. Novel designs described here that
`incorporate a combination of asymmetric 30-overhang with
`DNA residues in the blunt end offer a reliable approach to
`design Dicer–substrate RNA duplexes for use in RNAi
`applications.
`
`MATERIALS AND METHODS
`
`Chemically synthesized siRNAs
`
`All RNA oligonucleotides described in this study were
`synthesized and purified using high-performance liquid
`chromatography (HPLC) at Integrated DNA Technologies
`(Coralville, IA). All oligonucleotides were examined by elec-
`trospray ionization mass spectrometry (ESI-MS) and were
`within ±0.02% predicted mass and were further examined
`by capillary electrophoresis and were >90% molar purity.
`Final duplexes were prepared in sodium salt form. Duplexes
`are named by site (EGFPS2 is Site 2 in enhanced green fluor-
`escent protein) and by strand length. EGFPS2 27/27 is a blunt
`27mer RNA duplex. EGFPS2 25/27 has a 25 base top (sense,
`‘S’) strand and 27 base bottom (antisense, ‘AS’) strand with a
`2-base 30-overhang. EGFPS2 27/25 has a 27 base sense strand
`with a 2-base 30-overhang and a 25 base antisense strand.
`DNA bases have been substituted at various locations and
`inclusion is indicated as ‘D’ in compound names and DNA
`residues are identified using bold lower case letters in
`sequence; ‘p’ represents 50-phosphate. Starting with a 21mer
`sequence, an ‘R’ 27mer has added bases extending to the right
`side of this sequence (30 with respect to the target) and an ‘L’
`27mer has added bases extending to the left side of this
`sequence (50 with respect to the target). All RNA duplexes
`used in this study are listed in Table S1 (online Supplementary
`Material).
`
`In vitro dicing assays
`RNA duplexes (100 pmol) were incubated in 20 ml of 20 mM
`Tris, pH 8.0, 200 mM NaCl, 2.5 mM MgCl2 with or without
`1 U of recombinant human Dicer (Stratagene, La Jolla, CA)
`at 37C for 24 h. Samples were desalted using a Performa SR
`96 well plate (Edge Biosystems, Gaithersburg, MD). Electro-
`spray ionization liquid chromatography mass spectroscopy
`(ESI-LC-MS) of duplex RNAs pre- and post-treatment
`with Dicer were done using an Oligo HTCS system (Novatia,
`Princeton, NJ) (30), which consisted of ThermoFinnigan
`TSQ7000, Xcalibur data system, ProMass data processing soft-
`ware and Paradigm MS4Ô HPLC (Michrom BioResources,
`Auburn, CA). The liquid chromatography step employed
`before injection into the mass spectrometer (LC-MS) removes
`most of the cations complexed with the nucleic acids; some
`sodium ion can remain bound to the RNA and are visualized as
`minor +22 or +44 species, which is the net mass gain seen with
`substitution of sodium for hydrogen. All dicing experiments
`were performed at least twice.
`
`

`

`4142 Nucleic Acids Research, 2005, Vol. 33, No. 13
`
`EGFP RNAi assays
`
`HEK 293 cells were split in 24-well plates to 60% confluency
`in DMEM media one day prior to transfection. The indicated
`amounts of reporter and internal control DNAs and siRNAs
`were diluted in 50 ml of Opti-MEM I (Invitrogen, Carlsbad,
`CA) and mixed with 50 ml of Opti-MEM I diluted Lipofectam-
`ine 2000 (1 ml per well) (Invitrogen). After incubation at room
`temperature for 20–30 min, the complexes were added to cells
`in 0.4 ml of DMEM media. To normalize for transfection
`efficiency, either firefly luciferase or red fluorescent protein
`(RFP) reporter plasmids were included as internal controls.
`For the luciferase assay, the Steady Glo Luciferase Assay Kit
`(Promega, Madison, WI) was used according to manufacturer’s
`instruction. For RFP co-transfection, the indicated amount of
`EGFP reporter plasmid (pLEGFP-C1 vector, Clontech, Palo
`Alto, CA) was co-transfected with 20 ng of RFP reporter
`plasmid (pDsRed2-C1, BD Sciences, Franklin Lakes, NJ).
`After 24 h, RFP expression levels were monitored by fluor-
`escence microscopy. Only experiments where transfection
`efficiencies were >90% (as assessed by RFP expression)
`were evaluated. Levels of EGFP expression were measured
`24 h later. EGFP expression was determined either from the
`median number of EGFP-fluorescent cells determined by
`FACS (live cells) or by fluorometer readings (cell extracts).
`All transfections were minimally performed in duplicate and
`data averaged. Assays done in triplicate (or more) include
`error bars in data reporting.
`
`EGFP reporter assays of hnRNPH RNAi
`
`efficacy of hnRNPH-specific
`throughput,
`To facilitate
`duplexes were assayed using a synthetic reporter system where
`the complete coding region of the hnRNPH gene was cloned
`into the XhoI and BamHI sites of the EGFP gene in the expres-
`sion vector pLEGFP-C1 (Clontech, Palo Alto, CA) to make an
`EGFP-hnRNPH fusion protein. A PCR product was made
`from a human hnRNPH cDNA clone using the XhoI contain-
`ing forward primer 50-ACGCAGAACTCGAGTGTCTA-30
`and the BamHI containing reverse primer 50-TCACTGCTCC-
`TAGGTTACCT-30. The resulting PCR product was digested
`using XhoI and BamHI, and cloned into pLEGFP-C1 that
`had been similarly digested. Products were verified by DNA
`sequencing. The fusion protein reporter construct was used to
`directly measure activity of anti-hnRNPH reagents by change
`in EGFP fluorescence (31). Transfection and EGFP assays
`were performed as described above.
`
`Firefly luciferase RNAi assays
`
`HeLa cells were seeded at 5e4 cells per well in 24-well plates
`24 h prior to transfection in DMEM (Mediatech, Herndon,
`VA) containing 10% fetal bovine serum (Invitrogen). In
`each well, 100 ml of OptiMEM I containing 2.5 ml Lipofectam-
`ine was added to an equal volume of OptiMEM I containing
`1 mg pGL3-Control Vector (Promega), and the indicated
`duplex at either 20, 2 or 0.4 nM and incubated at room tem-
`perature for 30 min prior to transfection. Plates were washed
`with PBS and incubated for 4 h at 37C with lipoplex solution.
`Lipoplex solutions were replaced with 1 ml complete growth
`medium. At 48 h post-transfection, growth medium was
`replaced with 100 ml 1· Cell Culture Lysis Reagent (Promega).
`Plates were incubated at room temperature with gentle shaking
`
`for 1 h to allow complete cell lysis. The luminescence of cell
`lysates was determined using a Monolight 3010 luminometer
`(BD Pharmingen, San Diego, CA) and the Luciferase assay
`system (Promega). Substrate solution (100 ml) was added to
`10 ml cell lysate, and the resulting luminescent signal was
`integrated over 10 s. Results are presented in relative light
`units (RLU) as a percentage of the average signal for plasmid-
`only samples on the same plate. Mean and SD values for
`triplicate wells are presented for all treatments.
`
`La RNAi assays
`
`antigen
`human La
`the
`for
`specific
`RNA duplexes
`(NM_003142) were transfected into HEK293 cells in 6-well
`plates at 30% confluency as described above. Cellular extracts
`were prepared 72 h post-transfection. Western blots were per-
`formed as described previously (1). The anti-Enolase antibody
`was obtained from Biogenesis (Kingston, NH) and the anti-La
`antibody was kindly provided by Dr Ger Pruijn (Katholieke
`Universiteit Nijmergen, Netherlands).
`HeLa cells were split in 24-well plates at 35% confluency
`and were transfected the next day with Oligofectamine (Invit-
`rogen) using 1 ml per 65 ml OptiMEM I with RNA duplexes at
`the indicated concentrations. All transfections were performed
`in triplicate. RNA was harvested at 24 h post-transfection
`using SV96 Total RNA Isolation Kit (Promega). RNA was
`checked for quality using a Bioanalyzer 2100 (Agilent, Palo
`Alto, CA) and cDNA was prepared using 500 ng total RNA
`with SuperScript-II reverse transcriptase (Invitrogen) per
`manufacturer’s instructions using both oligo-dT and random
`hexamer priming. Real-time PCRs were done using an estim-
`ated 33 ng cDNA per 25 ml reaction using Immolase DNA
`Polymerase (Bioline, Randolph, MA) and 200 nM primers
`and probe. La-specific primers were La-For 50-GACCAACA-
`AGAATCCCTAAACA, La-Rev 50-CTTGCCCTGAAACT-
`GTACTT and probe La-P 50-FAM-AAGGGTAATAAAGC-
`TGCCCAGCCTGGGT-IowaBlackFQ. Cycling conditions
`employed were as follows: 50C for 2 min and 95C for
`10 min followed by 40 cycles of 2-step PCR with 95C for
`15 s and 60C for 1 min. PCR and fluorescence measurements
`were done using an ABI PrismÔ 7000 Sequence Detector
`(Applied Biosystems Inc., Foster City, CA). All data points
`were performed in triplicate. Expression data was normalized
`to internal control human acidic ribosomal phosphoprotein
`P0 (RPLP0) (NM_001002) levels which were measured
`in separate wells in parallel using primers RPLP0-For
`50-GGCGACCTGGAAGTCCAACT, RPLP0-Rev 50-CCAT-
`CAGCACCACAGCCTTC, and probe RPLP0-P 50-FAM-
`ATCTGCTGCATCTGCTTGGAGCCCA-IowaBlackFQ (32).
`
`Luciferase reporter vectors with EGFP and
`hnRNPH, S versus AS targeting
`
`A PCR generated fragment of the EGFP coding region span-
`ning sites EGFPS1 and EGFPS2 was cloned into the XhoI site
`located in the 30-untranslated region (30-UTR) of the human-
`ized Renilla luciferase gene of plasmid psiCHECKÔ-2
`(Promega). Primers containing an XhoI restriction site and
`EGFP nucleotides 67–85 (For, 50-TTTCTCGAGGTAAACGG-
`CCACAAGTTCA-30) and 291–311 (Rev, 50-TTTCTCGAG-
`TCGTCCTTGAAGAAGATGGTG-30) were used to generate
`a 245 bp EGFP PCR product. The PCR product was digested
`
`

`

`with XhoI and the fragment was cloned into a unique XhoI
`site located in the psiCHECKÔ-2 vector. Clones with both
`orientations (S and AS) were obtained and verified by DNA
`sequencing.
`A PCR generated fragment of the hnRNPH coding region
`spanning sites H1 and H3 was similarly cloned into the XhoI
`site located in the 30-UTR of the humanized Renilla luciferase
`gene of plasmid psiCHECKÔ-2. The fragment was 343 bp
`long including the region 90–432 of reference sequence
`NM_005520. Clones with both orientations (S and AS)
`were obtained. Maps of the ‘S’ and ‘AS’ psiCHECK-2 reporter
`vectors are shown in Figure S2 in the Supplementary Material.
`HEK293 cells were transfected with 150 ng of reporter
`vectors Luc-EGFP-‘S’ or Luc-EGFP-‘AS’ with the indicated
`amounts of EGFPS2 or control duplex RNAs as described
`above. HCT116 cells were transfected with 100 ng of reporter
`vectors Luc-hnRNPH-‘S’ or Luc-hnRNPH-‘AS’ with the
`indicated amounts of H3 or control duplex RNAs. Luciferase
`assays were performed 24 h post-transfection. Changes
`in expression of Renilla luciferase (target) were calculated
`relative to firefly luciferase (internal control).
`
`RESULTS
`
`Dicing patterns for EGFP RNA duplexes
`
`The products that result from in vitro digestion of various
`substrate RNA duplexes with recombinant human Dicer
`were
`visualized
`using
`ESI-MS
`(hereafter
`referred
`to as the ‘ESI-dicing assay’). A blunt 27mer derived from
`EGFP Site-1 (EGFPS1) was previously shown to produce
`two primary 21mer cleavage products by ESI-dicing (1).
`RNA duplexes derived from EGFP Site 2 (EGFPS2) sequence
`are studied here in greater detail and are shown in
`Figure 1 and Figure S1 (online Supplementary Material). In
`general, in vitro dicing of 27mer duplexes using recombinant
`human Dicer results in a heterogeneous set of products, most
`of which are 21mer or 22mer species with 50-phosphate. More
`rarely, 20mer and 23mer species are also seen; these species
`are usually inconsistent between repetitions. If a cleavage
`product includes the 50 end from the original chemically syn-
`thesized substrate duplex (i.e. no enzymatic cleavage event
`was needed to produce that end), the 50 end of the diced
`product remained identical to the substrate (50-phosphate or
`50-OH). 50 ends resulting from internal cleavage events show
`mass values consistent with the presence of 50-phosphate. This
`spectrum of diced products is consistent with the pattern seen
`by Elbashir in a collection of sequenced clones derived from
`diced longer dsRNAs (8). Peaks seen in a mass spectrometry
`trace can sometimes be identified to represent a single, unam-
`biguous, unique sequence. In other cases, it is not possible to
`unambiguously identify a specific sequence based solely upon
`mass if more than one 21mer with same base composition (and
`therefore the same mass) could be produced from cleavage of
`the substrate 27mer. In deconvolution of the mass spectra data,
`we have assigned duplex identity to unique species wherever
`possible and otherwise have identified products which are
`consistent with 21mer or 22mer duplexes with 2-base 30-over-
`hangs (instead of other combinations that would yield blunt
`duplexes or 1-base overhangs, etc.).
`
`Nucleic Acids Research, 2005, Vol. 33, No. 13
`
`4143
`
`ESI-dicing of the blunt 27mer substrate duplex EGFPS2 R
`27/27 shows a variety of mass peaks which are consistent with
`five duplex products, shown in Figure 1A. Using other blunt
`27mer duplex sequences (from other sites), we have seen 2, 3,
`4 or more duplex products result from dicing (data not shown).
`Elbashir reported in vitro dicing of 39, 52 and 111 bp dsRNA
`substrates using Drosophila extracts. Products were cloned
`and a heterogeneous collection of 21–22 base fragments
`were identified by DNA sequencing. While dicing appeared
`to generally initiate from one or both ends, no single product
`or subset of products was dominant (8). We cannot identify
`any obvious pattern that allows prediction of what specific
`21mer(s) will result from dicing a given blunt 27mer, making
`rational design of 27mer RNAi reagents difficult. We therefore
`tested a series of design variants to see if this heterogeneity
`could be reduced with the goal of finding a design for which
`cleavage patterns could be reliably predicted.
`Modification of one end of a blunt 27mer duplex with
`fluorescein inhibits dicing. Modification of both 30 ends
`with fluorescein completely blocks dicing (1). We tested if
`substitution of three DNA residues at the 50 or 30 end of either
`strand of a blunt 27mer duplex affected dicing patterns.
`Results are shown in Figure S1 (online Supplementary
`Material). DNA residues cannot be cleaved by Dicer and
`therefore directly alter cleavage patterns. Further, the DNA
`residues seem to reduce the likelihood of Dicer binding
`that end (assuming that Dicer binds the RNA duplex via
`the PAZ domain and then cuts 21–22 bases away) (33), espe-
`cially when positioned on the 30 end. Curiously, EGFPS2 R
`27/27(30D), the duplex with DNA residues positioned at the
`30 end of the antisense strand, was not diced to produce any
`21–22mer cleavage product (identical results were obtained in
`three attempts). While the use of terminal DNA residues can
`change and somewhat simplify dicing patterns, this approach
`alone is insufficient
`to truly direct dicing to predictable
`patterns.
`Naturally occurring substrates for Dicer include micro-
`RNAs (miRNAs). These species typically originate in the
`nucleus as long primary transcripts where they are processed
`to 70mer pre-miRNAs by the RNase III class endonuclease
`Drosha (34,35). Drosha products are shRNAs, which structur-
`ally look like an asymmetric duplex, having a single 2-base
`30-overhang on one side and a hairpin loop on the other side.
`These species are exported to the cytoplasm (36) where final
`processing by Dicer takes place (37). The 30-overhang may
`be important for Dicer processing. The presence of a single
`2-base 30-overhang has been shown to help direct ‘correct’
`dicing of synthetic shRNAs (21) and alters dicing patterns of
`synthetic linear 61mer duplexes (29).
`Asymmetric duplexes having one 2-base 30-overhang
`and one blunt end were studied using the ESI-dicing assay.
`Duplex EGFPS2 R 25/27 has two bases removed from the
`50 end of the sense strand compared with blunt duplex
`EGFPS2 R 27/27, providing a single 2-base 30-overhang.
`This duplex showed a much simplified dicing pattern,
`Figure 1B. Only one 21mer and one 22mer duplex were pro-
`duced. The observed pattern is consistent with a model where
`Dicer binds the 30-overhang of the substrate RNA and cleavage
`takes place 21–22 bases distant from this site (33). In fact,
`this pattern could be considered a single event as dicing gen-
`erates a single pair of related duplexes as ‘the product’ made
`
`

`

`4144 Nucleic Acids Research, 2005, Vol. 33, No. 13
`
`from digestion of the substrate duplex from a single unique
`binding or start site.
`The presence of a 30-overhang does not always restrict
`dicing to a simple pattern. Duplex EGFPS2 R 27/25 has
`two bases removed from the 50 end of the antisense strand
`compared with blunt duplex EGFPS2 R 27/27. This duplex
`showed a complex dicing pattern (Figure 1C) which is
`different from both the parent blunt duplex (Figure 1A)
`and the asymmetric duplex with the 30-overhang on the oppos-
`ite end (Figure 1B). Changing the bases present on the
`
`30-overhang from ‘CC’ to ‘GG’ did not reduce the complexity
`of dicing pattern seen for this duplex (data not shown).
`The two approaches of modifying dicing patterns were com-
`bined and DNA residues were placed at the 30 end (blunt end)
`of the antisense strand of asymmetric duplex EGFPS2 R 27/25,
`resulting in duplex EGFPS2 R 27/25D. This duplex gave a
`simplified dicing pattern with only a single 21mer and a single
`22mer species (Figure 1D). This new design strategy places an
`element on one end that is generally favorable for Dicer
`binding (2-base 30-overhang) and an element on the other
`
`A
`
`B
`
`

`

`Nucleic Acids Research, 2005, Vol. 33, No. 13
`
`4145
`
`end that is generally unfavorable for Dicer binding (blunt end
`with 30-DNA residues). This type of duplex appears to offer
`Dicer a single favorable binding site and would be predicted to
`result in a single 21mer product.
`Dicing patterns from the new design having a 2-base
`30-overhang on one end and blunt with 30-DNA residues on
`the other end were examined using additional duplexes.
`Duplex EGFPS2 R 25D/27 has a 30-overhang on the antisense
`strand and two DNA bases at the 30 end (blunt end) of the sense
`strand. Duplex EGFPS2 L 27/25D has the opposite design
`with a 30-overhang on the sense strand and two DNA bases
`at the 30 end (blunt end) of the antisense strand. If the design
`strategy works as predicted, these two different duplexes
`
`should both be diced into the same 21mer product. EGFPS2
`R 25D/27 diced into the expected 21mer/22mer pair with
`cleavage of 21–22 bases from the 30-overhang (Figure 1E).
`Similarly, EGFPS2 L 27/25D diced into the expected 21mer/
`22mer pair with cleavage 21–22 bases from the 30-overhang
`(Figure 1F). Thus, the same 21mer duplex was produced from
`two different substrate RNAs. Note, however, that the sister
`product (22mer) is necessarily different for each substrate
`since the single base addition occurs on opposite sides of
`the 21mer.
`To confirm that this cleavage pattern holds at other sites
`and is truly predictable, a similar related pair of asymmetric
`27mers were tested at EGFP Site-1 (Supplementary Table S1).
`
`C
`
`D
`
`

`

`4146 Nucleic Acids Research, 2005, Vol. 33, No. 13
`
`EGFPS1 R 25D/27 diced into the expected 21mer duplex with
`cleavage 21 bases from the 30-overhang (Figure 1G). In this
`instance, no 22mer was seen. Similarly, EGFPS1 L 27/25D
`diced into the expected 21mer/22mer pair with cleavage of
`21–22 bases from the 30-overhang (Figure 1H). Again, the
`same 21mer duplex was produced from two different 27mer
`substrate RNAs.
`
`Functional potency is different for ‘R’
`versus ‘L’ form RNA duplexes
`
`EGFPS2 duplexes were co-transfected into HEK293 cells
`with an EGFP expression plasmid. The blunt 27mer duplex
`(EGFPS2 R 27/27) was more potent in reducing EGFP expres-
`sion levels than the 21mer duplex (EGFPS2 21/21) (1). The
`L 27/25D asymmetric duplex was slightly less potent than
`the blunt 27mer while the R 25D/27 asymmetric duplex
`
`was significantly more potent than any other duplex tested at
`the EGFPS2 site (Figure 2A). A similarly matched pair of
`asymmetric 27mer duplexes was studied at EGFP Site-1
`(Figure 2B). As was observed previously for the EGFPS2 site,
`the ‘R’ asymmetric duplex was significantly more potent than
`the ‘L’ asymmetric duplex.
`We originally expected that the ‘R’-form and ‘L’-form
`duplexes would have similar functional potency since both
`result
`in the same antisense 21mer product after dicing
`(EGFPS2, Figure 1E and F; EGFPS1, Figure 1G and H).
`The ‘L’ and ‘R’ duplexes do produce different 22mer products
`after dicing. It is possible that the differential potency relates
`to these 22mer products. To test this possibility directly,
`RNA duplexes of 22mer length that correspond to the products
`identified from ESI-dicing of the ‘L’ and ‘R’-form 27mers
`for both EGFPS1 and EGFPS2 were co-transfected into
`HEK293 cells with an EGFP expression plasmid. For site
`
`E
`
`F
`
`

`

`Nucleic Acids Research, 2005, Vol. 33, No. 13
`
`4147
`
`G
`
`H
`
`Figure 1. ESI-MS analysis of in vitro dicing reactions. Mass spectra of duplexes are shown before (top) and after (middle) digestion with recombinant human
`Dicer. Sequence of the substrate RNA duplex is provided with detected cleavage products along with calculated molecular weight and strand length (bottom). RNA
`bases are upper case, DNA bases are lower case bold and ‘p’ represents 50-phosphate. (A) Blunt duplex EGFPS2 R 27/27; (B) asymmetric duplex EGFPS2 R 25/27;
`(C) asymmetric duplex EGFPS2 R 27/25; (D) asymmetric duplex EGFPS2 R 27/25(30D); (E) asymmetric duplex EGFPS2 R 25D/27; (F) asymmetric duplex
`EGFPS2 L 27/25D; (G) asymmetric duplex EGFPS1 R 25D/27; (H) asymmetric duplex EGFPS1 L 27/25D.
`
`EGFPS2, the ‘R-derived’ 22mer was significantly more potent
`than the ‘L-derived’ 22mer. This species could contribute to
`the higher potency observed for the ‘R’ form EGFPS2 27mer.
`However, for site EGFPS1 the ‘L-derived’ 22mer was 3-fold
`more potent
`than the ‘R-derived’ 22mer (Supplementary
`Figure S3). In this case, 22mer products cannot contribute
`to the observed higher potency of the ‘R’ form EGFPS1
`27mer. Therefore, although the different 22mer species that
`result from 27mer dicing can contribute to the ultimate
`potency of a given duplex, we believe that the generalized
`difference in potency seen between ‘R’ and ‘L’-form 27mers
`results from other aspects of Dicer/RISC biochemistry.
`Vermeulen reported that asymmetric 21mer duplexes with a
`
`single 30-overhang on the antisense strand were generally
`than duplexes with a single 30-overhang on
`more potent
`the sense strand (for 3 out of 4 duplexes studied in one
`gene target) (29). In this case, the duplexes tested were not
`Dicer substrates.
`target
`Dicer–substrate duplexes were studied in other
`systems to see if the seeming functional asymmetry between
`duplexes that are processed to the same 21mer product was
`reproducible at additional sites. RNA duplexes targeting two
`adjacent sites in the hnRNPH gene were tested for potency
`in triggering RNAi. Site H3 and neighboring site H1 (two
`base 50-shift) were studied for RNAi-mediated suppression
`of EGFP fluorescence using a modified EGFP expression
`
`

`

`4148 Nucleic Acids Research, 2005, Vol. 33, No. 13
`
`A
`
`B
`
`C
`
`

`

`D
`
`E
`
`Nucleic Acids Research, 2005, Vol. 33, No. 13
`
`4149
`
`Figure 2. ‘R’ form duplexes are more potent than ‘L’ form duplexes. Top: relative expression data are shown. Bottom: target sequences (S strand) are shown and
`transfected RNAi duplexes are aligned beneath in duplex form with sense strand top (50!30) and antisense strand bottom (30!50). RNA bases are upper case, DNA
`bases are lower case bold, and ‘p’ represents 50-phosphate. (A) Relative EGFP fluorescence was measured following co-transfection of an EGFP expression plasmid
`and EGFPS2 RNA duplexes; (B) relative EGFP fluorescence was measured following co-transfection of an EGFP expression plasmid and EGFPS1 RNA duplexes;
`(C) relative EGFP fluorescence was measured following co-transfection of an EGFP-hnRNPH fusion vector and hnRNPH RNA duplexes; (D) relative light emission
`from firefly luciferase was measured following co-transfection of a luciferase expression vector and luciferase RNA duplexes; (E) RNA duplexes specific for La
`antigen mRNA were transfected into cells at 2.5 nM concentration and protein extracts were prepared 72 h post-transfection. Western blots were done using anti-La
`antibodies and anti-enolase (control) antibodies

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket